AngioDynamics, Inc. (ANGO)
11.43
+0.22
(+1.96%)
USD |
NASDAQ |
Feb 24, 16:00
11.43
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Research and Development Expense (Quarterly) : 7.768M for Nov. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 569.00M |
| Intuitive Surgical, Inc. | 352.90M |
| Masimo Corp. | 30.50M |
| Abbott Laboratories | 721.00M |
| Plus Therapeutics, Inc. | 2.436M |